MedPath

Effect of Ketamine for pediatrics pai

Phase 2
Conditions
pain during Intravenous placement in pediatrics.
Registration Number
IRCT201504251764N3
Lead Sponsor
Vice chancellor for research,Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
70
Inclusion Criteria

children with no pain at baseline will enter the study? also children take part in the study who are able to take the drug orally.
Exclusion criteria: having any medical condition in which procedure is emergent and there is no 20-30 minutes chance to take analgesic; having any contraindication for prescribing ketamine (included but not limited to high blood pressure; high intracranial pressure; high intraocular pressure; Heart failure; Thyroid diseases; Respiratory system instability); the history of taking ketamine by patient in the last 24 hour in this center (in this study); 4. American Society of Anesthesiologists class= III; abnormal neurological exam; lack of parental consent; having any condition that makes evaluating pain difficult; Glasgow Coma Scale less than 15.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain while Intravenous placement in pediatrics. Timepoint: 30 minutes after taking oral Ketamine. Method of measurement: Measurement of pain in children ; pain score(Children's Hospital of Eastern Ontario Pain Scale, Visual Analog Scale).;Cooperation during catheter insertion. Timepoint: 30 minutes after taking the oral ketamine. Method of measurement: I.V Sedation Scale.
Secondary Outcome Measures
NameTimeMethod
Potential side effects due to use of oral ketamine. Timepoint: first 1 hour and 24 hours after taking of oral ketamine. Method of measurement: Checklist of side effects of ketamine.
© Copyright 2025. All Rights Reserved by MedPath